Industry news

• Biotechnopark establishes its research center in Koltsovo

  14 November 2012 Venture Business News

  Biotechnopark, which is currently under construction in Koltsovo near Novosibirsk, will establish a research center for collective use of upscale laboratory equipment for bacterial and viral researches. The question of further development of the Biotechnopark infrastructure was considered at a meeting of the regional government.

• Online Medical Startup Attracts $2M in Investment

  02 November 2012 Alexander Winning, The Moscow Times

  A Russian venture-capital fund and an American investor have agreed to invest $2 million in VitaPortal, an online medical startup aiming to improve Russians' access to information on doctors, medicine and healthy living.

• India, Russia to ease access to pharmaceutical markets

  01 November 2012 Sergey Ivanov, Combined Report, Russia and India Reports

  New regulation in both countries will cut down registration procedures that can take up to 3 years, opening up new avenues.

• Russian government to stimulate conduct of clinical trials by foreign pharma producers

  28 October 2012 The Pharma Letter

  The Russian government plans to actively attract the world's largest pharmaceutical manufacturers to the country, through the creation of conditions to carry out clinical trials of their drugs in the country and providing their access to Russian patients, according to local media reports.

• Takeda Pharma considering expansion in Russia and other BRIC countries

  26 October 2012 The Pharma Letter

  Amid the falling dynamics in the European Union and the USA, Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) is considering a big expansion into the Russian pharmaceutical market, along with other BRIC (Brazil, Russia, India and China) markets, in the coming years.

• Russia Establishes Clinical Trial Hub

  22 October 2012 Alex Philippidis, Insight & Intelligence

  Cost and speed play big roles in the country’s increased presence in the market.

• Strong pharma research is key to bringing in investment

  14 October 2012 Pharma Letter

  “Few people disagree that small drug discovery companies are vital to the health of the UK's pharma industry, and central to the government's aim of innovation-led growth. But private backers have become increasingly risk-averse," said Ana Nicholls, Healthcare Analyst at the Economist Intelligence Unit in response to an article in the UK’s Financial Times yesterday, titled Pioneering research on drugs is key to clinching investment.

• International quality standards for Belarusian pharmaceutical companies

  14 October 2012 News of Belarus

  Belarusian manufacturers of medications will switch to international quality standards, Mr Gennady Godovalnikov, Deputy Healthcare Minister of Belarus, Director of the Pharmaceutical Industry Department, told media.

• Abbott Laboratories to buy production facilities in Russia

  11 October 2012 Sergey Kashin, Dina Ushakova, Izvestia

  The rumored Abbott Laboratories deal could be one of the top three largest acquisitions in the history of Russia’s pharmaceutical market.